Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


5 Acta Obstet Gynecol Scand
16 Am J Obstet Gynecol
4 Am J Surg Pathol
3 Aust N Z J Obstet Gynaecol
4 BMC Cancer
5 Cancer
2 Clin Cancer Res
1 Eur J Cancer
6 Eur J Obstet Gynecol Reprod Biol
15 Fertil Steril
4 Gynecol Endocrinol
20 Gynecol Oncol
10 Hum Reprod
4 Int J Cancer
5 Int J Gynaecol Obstet
2 Int J Radiat Oncol Biol Phys
1 Int Urol Nephrol
4 J Clin Endocrinol Metab
7 Lancet
18 Obstet Gynecol
2 Oncogene
5 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Obstet Gynecol Scand

  1. ORTQVIST AK, Magnus MC, Aabakke AJM, Urhoj SK, et al
    Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark.
    Acta Obstet Gynecol Scand. 2023 Mar 17. doi: 10.1111/aogs.14552.
    PubMed         Abstract available

  2. RAVELLI ACJ, van der Post JAM, de Groot CJM, Abu-Hanna A, et al
    Does induction of labor at 41 weeks (early, mid or late) improve birth outcomes in low-risk pregnancy? A nationwide propensity score-matched study.
    Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14536.
    PubMed         Abstract available

  3. FOTHERINGHAM P, Safi N, Li Z, Anazodo A, et al
    Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
    Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14530.
    PubMed         Abstract available

  4. DEL BARCO E, Franco-Jarava C, Vargas M, Maiz N, et al
    Reference values for interleukin-6 in the amniotic fluid of asymptomatic pregnant women.
    Acta Obstet Gynecol Scand. 2023;102:480-485.
    PubMed         Abstract available

  5. TRAN VTT, Nguyen NA, Nguyen NT, Vo TTM, et al
    Development of children born to women with twin pregnancies treated with cervical pessary or vaginal progesterone: Follow-up of a randomized controlled trial.
    Acta Obstet Gynecol Scand. 2023 Mar 11. doi: 10.1111/aogs.14545.
    PubMed         Abstract available

    Am J Obstet Gynecol

  6. TOWERS CV, Katz E, Weitz B, Visconti K, et al
    Correction to 'Use of Naltrexone in treating opioid use disorder in pregnancy' [American Journal of Obstetrics and Gynecology 222/1 (2020) 83-84].
    Am J Obstet Gynecol. 2023 Mar 14:S0002-9378(22)00268.

  7. GRUNEBAUM A, Chervenak J, Pollet SL, Katz A, et al
    The Exciting Potential for ChatGPT in Obstetrics and Gynecology.
    Am J Obstet Gynecol. 2023 Mar 14:S0002-9378(23)00154.
    PubMed         Abstract available

  8. CORBISIERO MF, Tolbert B, Sanches M, Shelden N, et al
    Medicaid Coverage and Access to Obstetrics and Gynecology Subspecialists: Findings from a National Mystery Caller Study in the United States.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00147.
    PubMed         Abstract available

  9. SASSON AM, Hui M, Bhalwal A
    One step total hysteroscopic removal of cervical ectopic pregnancy.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00151.
    PubMed         Abstract available

  10. FOSTER KI, Flores Legarreta A, Kamat R, Handley KF, et al
    Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00148.
    PubMed         Abstract available

  11. DAVIES-TUCK ML, Davey MA, Hodges RL, Wallace EM, et al
    Fetal surveillance from 39 weeks' gestation to reduce stillbirth in South Asian born women.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00146.
    PubMed         Abstract available

  12. ZACHEK CM, Osuoji O, Qendro I, Aisagbonhi O, et al
    Complex cutaneous leishmaniasis in pregnancy.
    Am J Obstet Gynecol. 2023 Mar 9:S0002-9378(23)00141.

  13. WEI S
    Does the anti-hypertensive drugs at discharge are really related to the low incidence of readmission for postpartum preeclampsia?
    Am J Obstet Gynecol. 2023 Mar 7:S0002-9378(23)00143.

  14. THURMAN AR, Moench TR, Hoke M, Politch JA, et al
    ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Am J Obstet Gynecol. 2023 Mar 2:S0002-9378(23)00139.
    PubMed         Abstract available

  15. ALVAREZ RD, Chelmow D, Johnson DD, Griffin TR, et al
    Reimagining the Council of University Chairs of Obstetrics and Gynecology in evolving times.
    Am J Obstet Gynecol. 2023 Mar 1:S0002-9378(23)00079.

  16. JAUNIAUX E, Fox KA, Einerson B, Hussein AM, et al
    Perinatal assessment of Complex Cesarean Section Delivery: Beyond Placenta Accreta Spectrum.
    Am J Obstet Gynecol. 2023 Mar 1:S0002-9378(23)00137.
    PubMed         Abstract available

  17. ALERS RJ, Ghossein-Doha C, Canjels LPW, Muijtjens ESH, et al
    Attenuated cognitive functioning decades after preeclampsia.
    Am J Obstet Gynecol. 2023 Feb 28:S0002-9378(23)00136.
    PubMed         Abstract available

  18. MERCADEL AJ, Holloway SB, Saripella M, Lea JS, et al
    Risk Factors for Catheter-Associated Urinary Tract Infections Following Radical Hysterectomy for Cervical Cancer.
    Am J Obstet Gynecol. 2023 Feb 28:S0002-9378(23)00135.
    PubMed         Abstract available

  19. LYU T, Liang C, Liu J, Hung P, et al
    Risk for Stillbirth among Pregnant Individuals with SARS-CoV-2 Infection Varied by Gestational Age.
    Am J Obstet Gynecol. 2023 Feb 28:S0002-9378(23)00132.
    PubMed         Abstract available

  20. VENKATESH KK, Grobman WA, Wu J, Catalano P, et al
    Association of a Large-for-gestational Age Infant and Maternal Prediabetes and Diabetes 10-14 Years' Postpartum in the HAPO Follow-up Study.
    Am J Obstet Gynecol. 2023 Feb 25:S0002-9378(23)00133.

  21. KANTOROWSKA A, Cohen K, Oberlander M, Jaysing AR, et al
    Remote Patient Monitoring for Management of Diabetes in Pregnancy is Associated with Improved Maternal and Neonatal Outcomes.
    Am J Obstet Gynecol. 2023 Feb 23:S0002-9378(23)00116.
    PubMed         Abstract available

    Am J Surg Pathol

  22. MCCLUGGAGE WG, Rivera B, Chong AS, Clarke BA, et al
    Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    Am J Surg Pathol. 2023;47:490-496.
    PubMed         Abstract available

  23. MENDOZA RP, Wang P, Schulte JJ, Tjota MY, et al
    Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study.
    Am J Surg Pathol. 2023 Mar 3. doi: 10.1097/PAS.0000000000002031.
    PubMed         Abstract available

  24. ANDERSON WJ, Dong F, Fletcher CDM, Hirsch MS, et al
    A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa.
    Am J Surg Pathol. 2023 Mar 1. doi: 10.1097/PAS.0000000000002028.
    PubMed         Abstract available

  25. WIEDENHOEFER R, Schmoeckel E, Grube M, Sulyok M, et al
    L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression.
    Am J Surg Pathol. 2023 Feb 28. doi: 10.1097/PAS.0000000000002027.
    PubMed         Abstract available

    Aust N Z J Obstet Gynaecol

  26. BROWN J, Kanagaretnam D, Zen M
    Clinical practice guidelines for intrapartum cardiotocography interpretation: A systematic review.
    Aust N Z J Obstet Gynaecol. 2023 Mar 10. doi: 10.1111/ajo.13667.
    PubMed         Abstract available

  27. NANGRAHARY M, Graham DF, Pang J, Barnett W, et al
    Familial hypercholesterolaemia in pregnancy: Australian case series and review.
    Aust N Z J Obstet Gynaecol. 2023 Mar 8. doi: 10.1111/ajo.13657.
    PubMed         Abstract available

  28. NUGENT R, Wee A, Kearney L, de Costa C, et al
    The effectiveness of continuous positive airway pressure for treating obstructive sleep apnoea in pregnancy: A systematic review.
    Aust N Z J Obstet Gynaecol. 2023 Mar 3. doi: 10.1111/ajo.13654.
    PubMed         Abstract available

    BMC Cancer

  29. QIN L
    Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma.
    BMC Cancer. 2023;23:240.
    PubMed         Abstract available

  30. YANG Z, Yang X, Liu X, Ma K, et al
    Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
    BMC Cancer. 2023;23:243.
    PubMed         Abstract available

  31. BATES KM, Vathiotis I, MacNeil T, Ahmed FS, et al
    Spatial characterization and quantification of CD40 expression across cancer types.
    BMC Cancer. 2023;23:220.
    PubMed         Abstract available

  32. ZHANG H, Wang X, Li Y, Bai Y, et al
    The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.
    BMC Cancer. 2023;23:222.
    PubMed         Abstract available


  33. TANNE JH
    Women's lawsuit against Texas reveals nationwide problems over abortions.
    BMJ. 2023;380:p579.

  34. LIMB M
    The two doctors rule for authorising abortion should be scrapped, recommends review.
    BMJ. 2023;380:p563.

  35. LOOI MK
    Abortion: UN is urged to intervene in "human rights crisis" in US after ending of rights.
    BMJ. 2023;380:p521.


  36. FOSTER KI, Shaw KRM, Jin J, Westin SN, et al
    Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
    Cancer. 2023 Mar 17. doi: 10.1002/cncr.34724.
    PubMed         Abstract available

  37. CHINO JP, Moss HA, Swartz JJ, Gray BA, et al
    Care of the pregnant patient with cancer should include unfettered access to abortion.
    Cancer. 2023 Mar 12. doi: 10.1002/cncr.34686.

  38. NGUYEN T, Bhosale PR, Cassia L, Surabhi V, et al
    Malignancy in pregnancy: Multimodality imaging and treatment.
    Cancer. 2023 Mar 12. doi: 10.1002/cncr.34688.
    PubMed         Abstract available

  39. HENDRIKSE CSE, van der Ploeg P, van de Kruis NMA, Wilting JHC, et al
    Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low-grade ovarian carcinoma.
    Cancer. 2023 Mar 3. doi: 10.1002/cncr.34661.
    PubMed         Abstract available

  40. GRISHAM RN, Manning-Geist BL, Chui MH
    Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer.
    Cancer. 2023 Mar 3. doi: 10.1002/cncr.34658.

    Clin Cancer Res

  41. BATALINI F, Mina LA, Mina A
    Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Letter.
    Clin Cancer Res. 2023;29:1157.

  42. MARMOUSET V, Morice PM, Pages A, Leary A, et al
    Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response.
    Clin Cancer Res. 2023;29:1158-1159.

    Eur J Cancer

  43. WANG J, Cai L, Song Y, Sun T, et al
    Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study).
    Eur J Cancer. 2023;184:73-82.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  44. JANSEN LAW, Nijsten K, Limpens J, van Eekelen R, et al
    Perinatal outcomes of infants born to mothers with hyperemesis gravidarum: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;284:30-51.
    PubMed         Abstract available

  45. ASOGLU MR, Bahceci M
    Does endometrial thickness affect birth weight and serum levels of pregnancy-associated plasma protein-A in frozen cycles?
    Eur J Obstet Gynecol Reprod Biol. 2023;284:24-29.
    PubMed         Abstract available

  46. MITCHELL JM, Cullen S, McEvoy A, Crosby D, et al
    Can Anti-Mullerian Hormone levels predict future pregnancy outcomes in recurrent pregnancy loss?
    Eur J Obstet Gynecol Reprod Biol. 2023;284:20-23.
    PubMed         Abstract available

  47. POLITI S, Mastroroberto L, Ghi T
    The time has come for a paradigm shift in obstetrics' medico-legal litigations.
    Eur J Obstet Gynecol Reprod Biol. 2023;284:1-4.
    PubMed         Abstract available

  48. THAKUR P, Thakur V, Srivastava S
    Maternal and perinatal outcome in dengue and COVID-19 co-infected pregnancies.
    Eur J Obstet Gynecol Reprod Biol. 2023 Feb 26:S0301-2115(23)00076.

  49. RAMAIAH S, Bekas S, Annaiah TK
    Trichobezoar-A rare cause of hyperemesis in a pregnant woman.
    Eur J Obstet Gynecol Reprod Biol. 2023 Feb 23:S0301-2115(23)00052.
    PubMed         Abstract available

    Fertil Steril

  50. BULUN SE, Yildiz S, Adli M, Chakravarti D, et al
    Endometriosis and adenomyosis: shared pathophysiology.
    Fertil Steril. 2023 Mar 14:S0015-0282(23)00211.
    PubMed         Abstract available

  51. MAGARELLI PC, Berkley M, Cridennda D
    The birth of integrative reproductive medicine: finally, a randomized controlled trial for endometriosis treated with acupuncture!
    Fertil Steril. 2023 Mar 13:S0015-0282(23)00215.

  52. PIRTEA P, de Ziegler D, Ayoubi JM
    Fertil Steril. 2023 Mar 11:S0015-0282(23)00213.
    PubMed         Abstract available

  53. HOSSEINZADEH P, Wild RA, Hansen KR
    Diminished Ovarian Reserve: Risk for Preeclampsia in IVF pregnancies.
    Fertil Steril. 2023 Mar 8:S0015-0282(23)00209.

  54. WANG S, Wang D
    Management of interstitial pregnancy using laparoscopic salpingectomy with complete removal of the interstitial portion.
    Fertil Steril. 2023 Mar 4:S0015-0282(23)00174.
    PubMed         Abstract available

  55. MITSUNAMI M, Minguez-Alarcon L, Florio AA, Wang S, et al
    Intake of soy products and soy isoflavones in relation to ovarian reserve.
    Fertil Steril. 2023 Mar 3:S0015-0282(23)00172.
    PubMed         Abstract available

  56. LEONARDO-PINTO JP, Maghsoudlou P, Salazar GM, Clark NV, et al
    Diagnosis of gynecologic malignancy following treatment of presumed benign fibroid disease with Interventional Radiology procedures: a retrospective cohort study.
    Fertil Steril. 2023 Mar 3:S0015-0282(23)00171.
    PubMed         Abstract available

  57. ATA B, Linan A, Kalafat E, Ruiz F, et al
    Fertil Steril. 2023 Mar 2:S0015-0282(23)00168.
    PubMed         Abstract available

  58. Consideration of the gestational carrier: an Ethics Committee opinion.
    Fertil Steril. 2023 Feb 28:S0015-0282(23)00053.
    PubMed         Abstract available

  59. Retraction notice to "Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial".
    Fertil Steril. 2023;119:518.

  60. RIBEIRO R, Anselmi MC, Schneider GA, Rodrigues Furtado JP, et al
    First live birth after uterine transposition.
    Fertil Steril. 2023 Feb 28:S0015-0282(23)00166.
    PubMed         Abstract available

  61. MEYER JA, Quinn GP, Penfield CA
    Apples, Oranges, and Ectopic Pregnancies.
    Fertil Steril. 2023 Feb 27:S0015-0282(23)00165.

  62. Endometriosis and pregnancy loss: the importance of mitigating sources of bias.
    Fertil Steril. 2023 Feb 23:S0015-0282(23)00163.

  63. CUADRADO-TORROGLOSA I, Pacheco A, Barrio A, Garrido N, et al
    Increased cytotoxic natural killer cells in the endometrium alone cannot be considered the immunological cause of recurrent miscarriage.
    Fertil Steril. 2023 Feb 22:S0015-0282(23)00153.
    PubMed         Abstract available

  64. HARDEN S, Tan TY, Ku CW, Zhou J, et al
    Peritoneal autoantibody profiling identifies p53 as an autoantibody target in endometriosis.
    Fertil Steril. 2023 Feb 22:S0015-0282(23)00154.
    PubMed         Abstract available

    Gynecol Endocrinol

  65. ARYEE NA, Adu-Bonsaffoh K, Arko-Boham B, Quaye O, et al
    Thyroid hormone profile in preeclampsia patients: a case control study.
    Gynecol Endocrinol. 2023 Mar 16:2186136. doi: 10.1080/09513590.2023.2186136.
    PubMed         Abstract available

  66. NAPPI RE, Tiranini L, Bosoni D, Cucinella L, et al
    Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.
    Gynecol Endocrinol. 2023 Mar 14:2189971. doi: 10.1080/09513590.2023.2189971.
    PubMed         Abstract available

  67. MATEMANOSAK P, Peeyananjarassri K, Suwanrath C, Wattanakumtornkul S, et al
    Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review.
    Gynecol Endocrinol. 2023 Mar 6:2186138. doi: 10.1080/09513590.2023.2186138.
    PubMed         Abstract available

  68. YU F, Xue Y, Zhao Y, Zhang L, et al
    Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
    Gynecol Endocrinol. 2023 Feb 26:2183045. doi: 10.1080/09513590.2023.2183045.
    PubMed         Abstract available

    Gynecol Oncol

    Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: The evolution of a "pelvic" surgeon.
    Gynecol Oncol. 2023;170:A1-A3.

  70. LEE SS, Karpel HC, Oh C, Smith J, et al
    Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers.
    Gynecol Oncol. 2023;170:234-240.
    PubMed         Abstract available

  71. COLLARINO A, Fuoco V, Garganese G, Pasciuto T, et al
    Lymphatic mapping and sentinel node biopsy in vulvar melanoma: the first multicenter study and systematic review.
    Gynecol Oncol. 2023;170:153-159.
    PubMed         Abstract available

  72. STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
    Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial.
    Gynecol Oncol. 2023;170:143-152.
    PubMed         Abstract available

  73. LIU YL, Manning-Geist BL, Knezevic A, Deng L, et al
    Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
    Gynecol Oncol. 2023;170:93-101.
    PubMed         Abstract available

  74. LU L, Liu T, Wang S, Li J, et al
    Joint detection of multiple HPV-testing technologies and evaluation of clinicopathological characteristics discriminate between HPV-independent and low-copy HPV-associated cervical squamous cell carcinoma (CSCC) -an analysis of 3869 cases.
    Gynecol Oncol. 2023;170:59-69.
    PubMed         Abstract available

  75. WEI Z, Luy DD, Tang LW, Deng H, et al
    Gamma Knife radiosurgery for gynecologic metastases to the brain: Analysis of pathology, survival, and tumor control.
    Gynecol Oncol. 2023;172:21-28.
    PubMed         Abstract available

  76. HAROLD J, Bellone S, Manavell DD, Mutlu L, et al
    Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma".
    Gynecol Oncol. 2023;170:334.

  77. OSANN K, Wenzel L, McKinney C, Wagner L, et al
    Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
    Gynecol Oncol. 2023;171:151-158.
    PubMed         Abstract available

  78. SPENARD E, Geerts W, Lin Y, Gien LT, et al
    Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy.
    Gynecol Oncol. 2023;172:9-14.
    PubMed         Abstract available

  79. LECHARTIER C, Bernard J, Renaud MC, Plante M, et al
    Robotic-assisted surgery for endometrial cancer is safe in morbidly and extremely morbidly obese patients.
    Gynecol Oncol. 2023;172:15-20.
    PubMed         Abstract available

  80. TEWARI KS, Sill MW, Birrer MJ, Penson RT, et al
    Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical Cancer: A NRG oncology randomized study.
    Gynecol Oncol. 2023;171:141-150.
    PubMed         Abstract available

  81. HITCHINS MP, Alvarez R, Zhou L, Aguirre F, et al
    MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation.
    Gynecol Oncol. 2023;171:129-140.
    PubMed         Abstract available

  82. BJORNHOLT SM, Sponholtz SE, Mogensen O, Bouchelouche K, et al
    The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
    Gynecol Oncol. 2023;171:121-128.
    PubMed         Abstract available

  83. MOOLENAAR LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, et al
    Clinical outcomes of pelvic exenteration for gynecologic malignancies.
    Gynecol Oncol. 2023;171:114-120.
    PubMed         Abstract available

  84. BLANC-DURAND F, Yaniz-Galende E, Llop-Guevara A, Genestie C, et al
    A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
    Gynecol Oncol. 2023;171:106-113.
    PubMed         Abstract available

  85. GADDUCCI A, Multinu F, De Vitis LA, Cosio S, et al
    Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
    Gynecol Oncol. 2023;171:95-105.
    PubMed         Abstract available

  86. HENDRIKSE CSE, Theelen PMM, van der Ploeg P, Westgeest HM, et al
    The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;171:83-94.
    PubMed         Abstract available

  87. BLANK SV, Huh WK, Bell M, Dilley S, et al
    Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report.
    Gynecol Oncol. 2023;171:76-82.
    PubMed         Abstract available

  88. BENBROOK DM, Deng W, Gold MA, Rai R, et al
    Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
    Gynecol Oncol. 2023;171:67-75.
    PubMed         Abstract available

    Hum Reprod

  89. PEIGNE M, Simon V, Pigny P, Mimouni NEH, et al
    Changes in circulating forms of anti-Muullerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
    Hum Reprod. 2023 Mar 15:dead050. doi: 10.1093.
    PubMed         Abstract available

  90. STATEMA-LOHMEIJER CH, Schats R, Lissenberg-Witte BI, Kostelijk EH, et al
    A short versus a long time interval between semen collection and intrauterine insemination: a randomized controlled clinical trial.
    Hum Reprod. 2023 Mar 9:dead044. doi: 10.1093.
    PubMed         Abstract available

  91. GANER HERMAN H, Volodarsky-Perel A, Ton Nu TN, Machado-Gedeon A, et al
    Does embryo quality at transfer affect obstetric outcomes and placental findings?
    Hum Reprod. 2023 Mar 9:dead045. doi: 10.1093.
    PubMed         Abstract available

  92. GENARD-WALTON M, Warembourg C, Duros S, Mercier F, et al
    Serum persistent organic pollutants and diminished ovarian reserve: a single-exposure and mixture exposure approach from a French case-control study.
    Hum Reprod. 2023 Mar 3:dead028. doi: 10.1093.
    PubMed         Abstract available

  93. BEDAIWY MA, Fayek B, Yang EC, Iews MS, et al
    Prevalence, causes, and impact of non-visualized pregnancy losses in a recurrent pregnancy loss population.
    Hum Reprod. 2023 Mar 6:dead040. doi: 10.1093.
    PubMed         Abstract available

  94. MUNRO MG
    Adenomyosis and uterine stiffness: what is the chicken? Which is the egg?
    Hum Reprod. 2023 Mar 3:dead046. doi: 10.1093.

  95. Correction to: Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
    Hum Reprod. 2023 Mar 3:dead037. doi: 10.1093.

  96. WANG X, Shi W, Zhao S, Gong D, et al
    Whole exome sequencing in unexplained recurrent miscarriage families identified novel pathogenic genetic causes of euploid miscarriage.
    Hum Reprod. 2023 Mar 2:dead039. doi: 10.1093.
    PubMed         Abstract available

  97. MASSIN N, Abdennebi I, Porcu-Buisson G, Chevalier N, et al
    The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Hum Reprod. 2023 Mar 2:dead038. doi: 10.1093.
    PubMed         Abstract available

  98. PUY V, Dupeux M, Mayeur A, Grynberg M, et al
    Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
    Hum Reprod. 2023 Mar 1:dead041. doi: 10.1093.
    PubMed         Abstract available

    Int J Cancer

  99. PESOLA F, Rebolj M, Sasieni P
    Managing an extension of screening intervals: Avoiding boom and bust in health care workloads.
    Int J Cancer. 2023;152:2061-2068.
    PubMed         Abstract available

  100. WEVER BMM, van den Helder R, van Splunter AP, van Gent MDJM, et al
    DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples, and cervical scrapes.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34504.
    PubMed         Abstract available

  101. SILVA R, Glennon K, Metoudi M, Moran B, et al
    Unveiling the epigenomic mechanisms of acquired platinum-resistance in high-grade serous ovarian cancer.
    Int J Cancer. 2023 Mar 8. doi: 10.1002/ijc.34496.
    PubMed         Abstract available

  102. CHANG VC, Rhee J, Berndt SI, Moore SC, et al
    Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Int J Cancer. 2023 Feb 26. doi: 10.1002/ijc.34487.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  103. BAO H, Zhao Y, Zhang X, Bi H, et al
    HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: A post hoc analysis of a multicentric clinical study.
    Int J Gynaecol Obstet. 2022 Nov 29. doi: 10.1002/ijgo.14598.
    PubMed         Abstract available

  104. GIANNELLA L, Delli Carpini G, Di Giuseppe J, Gardella B, et al
    Should attention be paid to the cone depth in the fully visible transformation zone? Retrospective analysis of 517 patients with cervical intraepithelial neoplasia grade 3.
    Int J Gynaecol Obstet. 2023;161:137-143.
    PubMed         Abstract available

  105. TEHRANIAN A, Ghahghaei-Nezamabadi A, Seifollahi A, Mansouri P, et al
    Concurrent anorectal and cervical cytology in women with positive and negative cervical smear test results: A cross-sectional study.
    Int J Gynaecol Obstet. 2023;161:100-105.
    PubMed         Abstract available

  106. PANDA SR, Sharmila V, Kalidoss VK, Hota S, et al
    A triple-blind, randomized controlled trial, comparing combined letrozole and clomiphene versus only letrozole for ovulation induction in women with polycystic ovarian syndrome.
    Int J Gynaecol Obstet. 2023;161:63-70.
    PubMed         Abstract available

  107. VAAJALA M, Liukkonen R, Kuitunen I, Ponkilainen V, et al
    Obesity increases the odds of multiple pregnancies: A nationwide register-based cohort study in Finland.
    Int J Gynaecol Obstet. 2023 Mar 14. doi: 10.1002/ijgo.14748.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  108. LI B, Hirata E, Trejo JM, Garcia B, et al
    Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2023;115:1205-1216.

  109. PIFER PM, Jaishankar S, Bhargava R, Schad MD, et al
    Is substantial LVSI prognostic in patients with pathologically lymph node-negative endometrial cancer?
    Int J Radiat Oncol Biol Phys. 2023 Mar 7:S0360-3016(23)00214.
    PubMed         Abstract available

    Int Urol Nephrol

  110. LU W, Hu MJ, Zhu DD, Lin FJ, et al
    Clinical characteristics and prognosis of pregnancy-related acute kidney injury: a case series study.
    Int Urol Nephrol. 2023 Feb 28. doi: 10.1007/s11255-023-03484.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  111. RYSSDAL M, Vanky E, Stokkeland LMT, Jarmund AH, et al
    Immunomodulatory effects of metformin treatment in pregnant women with PCOS.
    J Clin Endocrinol Metab. 2023 Mar 14:dgad145. doi: 10.1210.
    PubMed         Abstract available

  112. SONG Q, Zhou T, Chen S, Liao Y, et al
    Association of gestational diabetes with the dynamic changes of gut microbiota in offspring from 1 to 6 months of age.
    J Clin Endocrinol Metab. 2023 Mar 4:dgad107. doi: 10.1210.
    PubMed         Abstract available

  113. JOHNSTONE EB, Gorsi B, Coelho E, Moore B, et al
    DIS3 Variants are Associated with Primary Ovarian Insufficiency: Importance of Transcription/Translation in Oogenesis.
    J Clin Endocrinol Metab. 2023 Mar 3:dgad126. doi: 10.1210.
    PubMed         Abstract available

  114. DIACINTI D, Diacinti D, Iannacone A, Pepe J, et al
    Bone Marrow Adipose Tissue (BMAT) is increased in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2023 Feb 28:dgad116. doi: 10.1210.
    PubMed         Abstract available


  115. MOUHANNA JN, Simms-Cendan J, Pastor-Carvajal S
    The Menstrual Cup: Menstrual Hygiene With Less Environmental Impact.
    JAMA. 2023 Mar 17. doi: 10.1001/jama.2023.1172.

  116. VALENT AM, Caughey AB
    Comprehensive Management of Type 2 Diabetes During Pregnancy.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.0929.

  117. LUO M, Chai Q, Fei Y
    Unintended Pregnancy and Maternal and Infant Health Outcomes.
    JAMA. 2023;329:765.

  118. NELSON HD, Ahrens K, Fu R
    Unintended Pregnancy and Maternal and Infant Health Outcomes-Reply.
    JAMA. 2023;329:765-766.

  119. ROCA A, Camara B, Bognini JD, Nakakana UN, et al
    Effect of Intrapartum Azithromycin vs Placebo on Neonatal Sepsis and Death: A Randomized Clinical Trial.
    JAMA. 2023;329:716-724.
    PubMed         Abstract available

  120. RICHARDS EG, Rehmer JM, Falcone T
    Perforation During Gynecological Procedures.
    JAMA. 2023 Mar 3. doi: 10.1001/jama.2023.0687.

  121. HARRIS E
    ADHD Drugs in Pregnancy Not Linked to Children's Brain Development.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2890.

  122. HARRIS E
    On-Demand Male Contraceptive Compound Promising in Mouse Study.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2888.


  123. LEDERMAN S, Ottery FD, Cano A, Santoro N, et al
    Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.
    Lancet. 2023 Mar 13:S0140-6736(23)00085-5. doi: 10.1016/S0140-6736(23)00085.
    PubMed         Abstract available

  124. PRAGUE JK
    Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms.
    Lancet. 2023 Mar 13:S0140-6736(23)00353-7. doi: 10.1016/S0140-6736(23)00353.

  125. KAKURU A, Jagannathan P
    Can we reduce malaria in pregnancy and improve birth outcomes?
    Lancet. 2023 Mar 10:S0140-6736(23)00101-0. doi: 10.1016/S0140-6736(23)00101.

  126. MADANITSA M, Barsosio HC, Minja DTR, Mtove G, et al
    Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlle
    Lancet. 2023 Mar 10:S0140-6736(22)02535-1. doi: 10.1016/S0140-6736(22)02535.
    PubMed         Abstract available

  127. MORLEY LC, Sparey C, Wijeratne D, Turner K, et al
    A planned caesarean hysterectomy for placenta accreta spectrum at 35 weeks of gestation: antenatal identification and a multidisciplinary approach to manage an increasing condition.
    Lancet. 2023;401:856-857.

  128. CLUVER C, de Groot C, Mol BW, Murphy KE, et al
    The need for appropriate language in the debate on medicalisation of pregnancy.
    Lancet. 2023;401:818-819.

  129. HAWKES S, Kedia S, Odunga S, Dahal M, et al
    From flowers to menstrual-flow trackers: the corporatisation of women's equality and wellbeing.
    Lancet. 2023 Mar 7:S0140-6736(23)00456-7. doi: 10.1016/S0140-6736(23)00456.

    Obstet Gynecol

  130. SAMPSON MM, Magee G, Schrader EA, Dantuluri KL, et al
    Mpox (Monkeypox) Infection During Pregnancy.
    Obstet Gynecol. 2023 Mar 16. doi: 10.1097/AOG.0000000000005170.
    PubMed         Abstract available

  131. LIN CY, Cassidy AG, Li L, Prahl MK, et al
    Nirmatrelvir-Ritonavir (Paxlovid) for Mild Coronavirus Disease 2019 (COVID-19) in Pregnancy and Lactation.
    Obstet Gynecol. 2023 Mar 16. doi: 10.1097/AOG.0000000000005152.
    PubMed         Abstract available

  132. THOMA ME, Declercq ER
    Changes in Pregnancy-Related Mortality Associated With the Coronavirus Disease 2019 (COVID-19) Pandemic in the United States.
    Obstet Gynecol. 2023 Mar 16. doi: 10.1097/AOG.0000000000005182.
    PubMed         Abstract available

  133. EGAN RC, Chaiken SR, Derrah K, Doshi U, et al
    Universal Tetanus-Diphtheria-Pertussis Vaccination During Pregnancy: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005103.
    PubMed         Abstract available

  134. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    PubMed         Abstract available

  135. NEAL-PERRY G, Cano A, Lederman S, Nappi RE, et al
    Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005114.
    PubMed         Abstract available

    Crisis Pregnancy Centers.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005112.

  137. ROBISON K, Wohlrab K, Howe CJ, Richter HE, et al
    Endometrial Cancer Surgery With or Without Concomitant Stress Urinary Incontinence Surgery.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005059.
    PubMed         Abstract available

  138. MCEVOY A, Corbett GA, Nolan C, Daly R, et al
    Outcomes of Uterine Rupture in the Setting of the Unscarred Compared With the Scarred Uterus.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005108.
    PubMed         Abstract available

  139. COREY L, Seaton R, Ruterbusch JJ, Bretschneider CE, et al
    Concurrent Surgery for Locoregional Gynecologic Cancers and Pelvic Floor Disorders in a Population of Patients With Medicare Insurance.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005085.
    PubMed         Abstract available

  140. XU KY, Jones HE, Schiff DM, Martin CE, et al
    Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005117.
    PubMed         Abstract available

    Is Two Better Than One?: Concurrent Surgery for Gynecologic Cancer and Pelvic Floor Disorders.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005133.

  142. MATTESON KA, Schimpf MO, Jeppson PC, Thompson JC, et al
    Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005104.
    PubMed         Abstract available

  143. LIU L, Tian H, Lin D, Zhao L, et al
    Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005080.
    PubMed         Abstract available

  144. WAGAR MK, Forlines GL, Moellman N, Carlson A, et al
    Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005118.
    PubMed         Abstract available

  145. WHITESIDE JL, Tumin D, Hohmann SF, Harris A, et al
    Determinants of Cost for Outpatient Hysterectomy for Benign Indications in a Nationwide Sample.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005109.
    PubMed         Abstract available

  146. MCELWEE ER, Oliver EA, McFarling K, Haney A, et al
    Risk of Stillbirth in Pregnancies Complicated by Diabetes, Stratified by Fetal Growth.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005102.
    PubMed         Abstract available

  147. SHIVRAJ P, Chadha R, Novak AR, Dynis DN, et al
    Knowledge, Judgment, and Skills in Reproductive Health Care and Abortion Are Essential to the Practice of Obstetrics and Gynecology.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005111.
    PubMed         Abstract available


  148. MOSKOVICH D, Finkelshtein Y, Alfandari A, Rosemarin A, et al
    Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.
    Oncogene. 2023 Mar 15. doi: 10.1038/s41388-023-02629.

  149. CHEN K, Yuan X, Wang S, Zheng F, et al
    MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage.
    Oncogene. 2023 Mar 15. doi: 10.1038/s41388-023-02650.
    PubMed         Abstract available

    PLoS One

  150. YAN L, Xiao X, He L, Shi L, et al
    Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    PLoS One. 2023;18:e0282833.
    PubMed         Abstract available

  151. REZENDE GP, Yela Gomes DA, Benetti-Pinto CL
    Prevalence of abnormal uterine bleeding in Brazilian women: Association between self-perception and objective parameters.
    PLoS One. 2023;18:e0282605.
    PubMed         Abstract available

  152. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    PubMed         Abstract available

  153. LEE YE, Park S, Lee KY, Song JE, et al
    Risk factors based on myoma characteristics for predicting postoperative complications following cesarean myomectomy.
    PLoS One. 2023;18:e0280953.
    PubMed         Abstract available

  154. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
    Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    PLoS One. 2023;18:e0282853.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.